Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | +0.79% | +6.35% | -28.04% |
Apr. 09 | Harvard Bioscience Reducing Headcount | MT |
Apr. 09 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 126M | Capitalization | 167M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 3M | EV / Sales 2024 * | 1.47 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
-770
x | P/E ratio 2025 * |
51.3
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | +0.79% | ||
1 week | +6.35% | ||
Current month | +0.79% | ||
1 month | -13.87% | ||
3 months | -14.82% | ||
6 months | -10.47% | ||
Current year | -28.04% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.85 | +0.79% | 39,597 |
24-05-02 | 3.82 | 0.00% | 84,969 |
24-05-01 | 3.82 | 0.00% | 141,752 |
24-04-30 | 3.82 | +2.96% | 206,610 |
24-04-29 | 3.71 | +2.49% | 212,747 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.04% | 167M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- HBIO Stock